RANDOMIZED TRIAL OF MEGESTROL-ACETATE VS MEGESTROL-ACETATE TAMOXIFEN FOR THE MANAGEMENT OF PROGRESSIVE OR RECURRENT EPITHELIAL OVARIAN-CARCINOMA

被引：27

作者：

BELINSON, JL ^{[1
]}

MCCLURE, M ^{[1
]}

BADGER, G ^{[1
]}

机构：

[1] UNIV VERMONT,COLL MED,BIOMETRY FACIL,BURLINGTON,VT 05405

来源：

关键词：

D O I：

10.1016/0090-8258(87)90208-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：151 / 155

页数：5

共 17 条

[1] BELINSON JL, 1984, CANCER, V54, P1983, DOI 10.1002/1097-0142(19841101)54:9<1983::AID-CNCR2820540933>3.0.CO
[2] 2-2
[3] BELINSON JL, IN PRESS GYNECOL ONC
[4] FORD LC, 1983, GYNECOL ONCOL, V115, P299
[5] GEISLER HE, 1983, OBSTET GYNECOL, V61, P95
[6] PHASE-II TRIAL OF MEDROXYPROGESTERONE ACETATE IN ADVANCED OVARIAN-CANCER - AN EORTC GYNECOLOGICAL CANCER COOPERATIVE GROUP-STUDY
HAMERLYNCK, JVTH
MASKENS, AP
MANGIONI, C
VANDERBURG, MEL
WILS, JAMJ
VERMORKEN, JB
ROTMENSZ, N
[J]. GYNECOLOGIC ONCOLOGY, 1985, 22 (03) : 313 - 316
[7] MALKASIAN GD, 1977, CANCER TREAT REP, V61, P913
[8] HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED EPITHELIAL OVARIAN-CANCER RESISTANT TO 1ST-LINE OR 2ND-LINE CHEMOTHERAPY
MANGIONI, C
FRANCESCHI, S
LAVECCHIA, C
DINCALCI, M
[J]. GYNECOLOGIC ONCOLOGY, 1981, 12 (03) : 314 - 318
[9] MANTEL N, 1966, CANCER CHEMOTHER REP, V50, P1963
[10] MYERS AM, 1981, CANCER, V48, P2368, DOI 10.1002/1097-0142(19811201)48:11<2368::AID-CNCR2820481105>3.0.CO